MOSCOW, Oct 30 (PRIME) -- The Russian Direct Investment Fund (RDIF), Uniao Quimica Farmaceutica Nacional and the government of the Brazilian state of Parana have applied for registration of the Sputnik V vaccine to the national sanitary authority, the RDIF said in a statement on Friday.
"The RDIF, company Uniao Quimica Farmaceutica Nacional and the government of the state of Parana announce having preliminarily sent the documents for registration of the Russian vaccine Sputnik V to the Brazil National Health Surveillance Agency (ANVISA)," the fund said.
The Russian Healthcare Ministry registered the world’s first coronavirus vaccine on August 11. At first, the Gamaleya institute and pharmaceutical company Binnopharm were to produce the vaccine, and R-Pharm and Generium were to join them soon. Multi-industry holding Sistema said that Binnopharm’s capacities allow it to produce 1.5 million doses of the vaccine per year, and that it planned to start mass production until the end of 2020.
End %%mk/jst%%
|
|
